🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the relative vaccine effectiveness of quadrivalent...
Status
Recruiting
Location
Kaiser Permanente Northern California (entire region)
Start Date
2023-08-17
Trial ID
NCT06029933
The purpose of this research is to evaluate blood samples from HIV infected...
Status
Active Not Recruiting
Location
University of Miami
Start Date
2020-11-18
Trial ID
NCT04304768
Treatments Being Tested
The purpose of this study is to see how much antibody (proteins produced by...
Status
Completed
Location
Saint Louis University - Center for Vaccine Development
Start Date
2010-09
Trial ID
NCT01173211
This study evaluates the immunogenicity and safety of 'IL-YANG Quadrivalent...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02677493
In this study the investigators propose a randomized controlled trial to ev...
Status
Unknown
Location
Center For Human Reproduction
Start Date
2017-01-19
Trial ID
NCT02946177
Treatments Being Tested
Observational and randomized studies suggest that influenza vaccine may red...
Status
Completed
Location
Chru de Trousseau
Start Date
2024-10-21
Trial ID
NCT06508437
Treatments Being Tested
This study will investigate markers, mechanisms and define general predicto...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT03022422
Treatments Being Tested
To evaluate the safety of a single intramuscular (IM) injection of trivalen...
Status
Completed
Location
University Hospital Ghent, Center for Vaccinology, Prof.Dr. G Leroux Roels
Start Date
2012-07
Trial ID
NCT01636102
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of I...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT02263131
Treatments Being Tested